Eric Siemers Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

ABOS Quotes by TradingView

Eric Siemers is Chief Medical Officer of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 170,298 shares of ABOS, which is worth approximately $270,773. The most recent transaction as insider was on Jan 21, 2025, when has been sold 3,219 shares (Common Stock) at a price of $1.59 per share, resulting in proceeds of $5,118. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 170K
44.84% 3M change
44.84% 12M change
Total Value Held $270,773

Eric Siemers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 21 2025
SELL
Open market or private sale
$5,118 $1.59 p/Share
3,219 Reduced 1.86%
170,298 Common Stock
Jan 06 2025
BUY
Grant, award, or other acquisition
-
66,800 Added 27.8%
173,517 Common Stock
Jan 03 2025
SELL
Open market or private sale
$20,089 $1.85 p/Share
10,859 Reduced 9.24%
106,717 Common Stock
Jan 18 2024
SELL
Open market or private sale
$11,590 $3.71 p/Share
3,124 Reduced 2.59%
117,576 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
94,000 Added 43.78%
120,700 Common Stock
Jan 17 2023
BUY
Grant, award, or other acquisition
-
26,700 Added 50.0%
26,700 Common Stock
ES

Eric Siemers

Chief Medical Officer
Charlottesville, VA

Track Institutional and Insider Activities on ABOS

Follow Acumen Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABOS shares.

Notify only if

Insider Trading

Get notified when an Acumen Pharmaceuticals, Inc. insider buys or sells ABOS shares.

Notify only if

News

Receive news related to Acumen Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABOS